HealthsystemCIO.com June 25, 2025
C-suite leaders say they are not buying just technology, but a partner who understands the nuances of their environments and can help achieve real results.
The latest research from KLAS reveals that hospital executives are placing increased importance on transparent, predictable pricing as they assess potential technology vendors. According to the report, cost concerns are no longer confined to the CFO’s office—executives across operational and clinical roles express frustration with opaque pricing models and unexpected fees that can derail planning and erode trust.
CFOs are particularly wary of vendors who introduce switching costs late in the sales process or fail to provide multi-year financial modeling tools. CMIOs, meanwhile, question technology purchases that don’t yield demonstrable improvements in clinical workflows,...







